Newer antifungals valuable for onychomycosis

Guttman, Cheryl
April 2002
Dermatology Times;Apr2002 Supplement 2, Vol. 23 Issue 4, pS14
Trade Publication
Focuses on the antifungal agents for the treatment of onychomycosis on patients. Definition of onychomycosis; Efficacy of terbinafine and itraconazole in eradicating fungal nail infection; Restrictions on the administration of itraconazole in patients with evidence of ventricular dysfunction and statin lipid-lowering medications.


Related Articles

  • CONTINUOUS TERBINAFINE VERSUS INTERMITTENT ITRACONAZOLE FOR TOENAIL ONYCHOMYCOSIS. Warrick, Delilah // Journal of Family Practice;Jul1999, Vol. 48 Issue 7, p492 

    The article cites a research study that examines how do continuous terbinafine and intermittent itraconazole compare in efficacy and safety for the treatment of toenail onychomycosis. Onychomycosis is one of the most common nail diseases, and one of the few that is treatable. Commonly used...

  • Toenail Cure Rates. Hill, Suzette // Dermatology Times;Jun2003, Vol. 24 Issue 6, p20 

    Discusses the efficacy of itraconazole and terbinafine in the treatment of toenail onychomycosis. Prognostic factors of mycological cure following treatment with oral antifungals; Use of mycological cultures at 24 weeks in improving treatment efficacy.

  • Oral Therapy for the Treatment of Onychomycosis. Kirchner, Jeffrey T. // American Family Physician;01/15/2001, Vol. 63 Issue 2, p345 

    Presents an abstract of the study `Onychomycosis: Improved Cure Rates With Itraconazole and Terbinafine,' by T.K. Harrell et al., from the July-August 2000 issue of the `Journal of the American Board of Family Practice.'

  • Terbinafine prescribing rate boosted by pharma advertising campaign.  // PharmacoEconomics & Outcomes News;3/13/2004, Issue 448, p7 

    Discusses research being done on the outcome of a nationwide information campaign for people with onychomycosis in the Netherlands. Reference to a study by G. W't Jong and colleagues published in a March 2004 issue of the "British Medical Journal"; Impact of the advertising campaign on the...

  • Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. Jong, Geert W't; Stricker, Bruno H. Ch.; Sturkenboom, Miriam C.J.M. // BMJ: British Medical Journal (International Edition);4/17/2004, Vol. 328 Issue 7445, p931 

    Presents a study of the changes in rates of prescriptions of oral terbinafine and itraconazole and the consultation rate before and after the start of an information campaign by Novartis, the manufacturer of terbinafine. Description of the study and its results; Comment that the rate of...

  • Terbinafine Is More Effective Than Itraconazole In Treating Toenail Onychomycosis: Results from a Meta-analysis of Randomized Controlled Trials. Krob, Alexander H.; Fleischer Jr., Alan B.; D'Agostino, Ralph; Feldman, Steven R. // Journal of Cutaneous Medicine & Surgery;Jul/Aug2003, Vol. 7 Issue 4, p306 

    Background: Toenail onychomycosis is a challenge for clinicians to treat, and this challenge is compounded by conflicting information in the medical literature concerning the efficacy of the two principal agents used in its treatment: terbinafine and itraconazole. Objective: The purpose of this...

  • Candida dubliniensis: A rare cause of nail infection. J. Kalsy; J. Kaur // Journal of Pakistan Association of Dermatologists;Oct-Dec2012, Vol. 22 Issue 4, p370 

    Candida dubliniensis is a newly described fungal opportunistic pathogen that is closely related phylogenetically to C. albicans. It is mostly isolated from patients with immunodeficiency and few cases develop quick resistance to routine treatment and delay in result outcome. Here we report a...

  • Iontophoretic Terbinafine HCL 1.0% Delivery Across Porcine and Human Nails. Amichai, Boaz; Mosckovitz, Rachel; Trau, Henri; Sholto, Orit; Ben-Yaakov, Shirly; Royz, Michael; Barak, David; Nitzan, Boaz; Shemer, Avner // Mycopathologia;May2010, Vol. 169 Issue 5, p343 

    Onychomycosis is a common disease. Topical treatment is usually not effective due to limitation of trans-nail delivery of antifungal drugs. Successful treatment of deep-seated nail infections remains elusive as the delivery of efficacious levels of antifungal drug to the site of action is very...

  • ORAL TREATMENT OF ONYCHOMYCOSIS. Ellis, Mark R.; Kane, Kevin Y. // Journal of Family Practice;Apr1999, Vol. 48 Issue 4, p252 

    The article cites a research study that analyzes how effective are the newer oral antifungals for the treatment of toenail onychomycosis. Standard topical antifungals are ineffective for the treatment of onychomycosis, and treatment with griseofulvin and ketoconazole is hampered by low cure...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics